Lake Bleu Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Lake Bleu Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 9, 2025	Sanegene Bio	$110.0M Series B	—	Eli Lilly and Company, Invus, K2 Venture Partners, Legend Capital, Northern Light Venture Capital, Oriza Holdings, Qiming Venture Partners, Sino Biopharmaceutical, SymBiosis, Tencent, TF Capital, TruMed, Vivo Capital
Aug 28, 2023	HC Scientific	$41.1M Series B Extension	Lake Bleu Capital	—
Jul 13, 2023	CoJourney	$30.0M Series A	Legend Capital	—
Jun 30, 2022	BANGBANG ROBOT	$14.9M Series B	Lake Bleu Capital	Yangfeng TAO
Jan 1, 2022	GenFleet Therapeutics	$78.5M Series C	Zeng Zhiqiang	Baidu Ventures, CDH Investments, Cherami Investment Group, Dyee Capital, HM Capital, Panlin Capital, Qiaojing Eastern Investment, Shanjin Asset, Suxin Venture Capital
Aug 17, 2021	Meditrust	$308.7M Series C	Boyu Capital, Janchor Partners	AIHC Capital, Bank of China Group Investment, China Everbright, China Renaissance, CICC Capital, Lilly Asia Ventures, Marathon Venture Partners, New Alliance Capital, Shanghai Biopharmaceutical Fund, Sinovation Ventures
Jul 28, 2021	Lupeng Pharmaceutical	$35.0M Pre-Series B	Temasek	Fontus Capital, Kaitai Capital, Bin Li, Lilly Asia Ventures, TF Capital
Jun 23, 2021	Exegenesis Bio	$50.0M Series B	Hillhouse Capital Group	CPE, LYFE Capital, Temasek Holdings
Apr 22, 2021	WeMed	$46.2M Series D	Bin Li Li Bin	申红权
Mar 30, 2021	AffaMed Therapeutics	$170.0M Series B	Bin Li	Wei Fu, Fountainhead Partners, Orion Science Capital, Partners Investment, Superstring Capital
Mar 23, 2021	Brii Biosciences	$155.0M Series C	Invesco	GIC
Nov 9, 2019	Akeso	$150.0M Series D	Loyal Valley Capital, Sino Biopharmaceutical	AIHC Capital, CDG International, OrbiMed, Shenzhen Capital Group